• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-Deoxy-D-Glucose (2DG)
      • Acacia Cyanophylla Flower
      • Acori Graminei Rhizoma
      • Aegle Marmelos Correa
      • Agaricus Blazei
      • Aged Garlic Extract
      • Aframomum Melegueta
      • Aloe Arborescens
      • Albizia
      • Alpinia Officinarum
      • Alternanthera Sessilis
      • American Ginseng
      • Amygdalin
      • Anacyclus Pyrethrum
      • Angelica Archangelica
      • Angelica Sinensis
      • Antrodia
      • Artichoke Leaf
      • Artocarpin
      • Ajuga Turkestanica
      • Ashwagandha
      • Aspalathin
      • Astragalus Complanatus
      • Avena Sativa
      • Bacopa Monnieri
      • Bavachin
      • Bee Pollen
      • Betulinic Acid
      • Boswellic Acid
      • Brevilin A
      • Campesterol
      • Casticin
      • Chrysin
      • Cinnamomum Zeylanicum
      • Citrullus Colocynthis
      • Citrus Reticulata Peel
      • Codonopsis
      • Costunolide
      • Cucurbitacin D
      • Daidzein
      • Decursin
      • Delphinidin
      • Digitalis Purprea (Digoxin)
      • Diosmin
      • Embelin
      • Gallic Acid
      • Glycitein
      • Glycyrrhizin
      • Hyperforin
      • Icariin
      • Isorhamnetin
      • Isoorientin
      • Isovitexin
      • Jaceosidin
      • Kaempferol
      • Kurarinone
      • Lemon balm
      • Licoricidin
      • Lipoic acid
      • Lupeol
      • Magnolol
      • Mulberry Leaf
      • Naringenin
      • Nobiletin
      • Oleacein
      • Oleanolic acid
      • Oridonin
      • Parthenolide
      • Phloroglucinol
      • Piceatannol
      • Pristimerin
      • Proanthocyanidins
      • Procyanidin B3
      • Pseudolaric acid b
      • Pterostilbene
      • Rutin
      • Solidago Virgaurea
      • Tangeretin
      • Taraxasterol
      • Trichostatin A
      • Wedelolactone
      • Wogonin
      • Yerba Mate
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • AMPK
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI COVID-19 EFFECTS OF FLAVONOIDS AND POLYPHENOLS (1000 SCIENTIFIC STUDIES)
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • EPIGENETIC MODIFIERS
      • FGF21
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • IKK
      • IL-6/STAT3
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTOR: THE RAPID AGING PATHWAY
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PHYTOECDYSTEROIDS
      • PPARY2
      • PREMATURE SENESCENCE
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    ANTI ADIPOGENIC
    July 6, 2020
    CYP2E1
    September 1, 2020
    1. Molecular regulation of adipogenesis
    2. Transcriptional regulation of adipogenesis
    3. Regulating adipogenesis
    4. New developments in adipogenesis
    5. Inhibition of adipogenesis by Wnt signaling
    6. Regulation of Wnt signaling during adipogenesis
    7. Angiogenesis modulates adipogenesis and obesity
    8. C/EBPα induces adipogenesis through PPARγ: a unified pathway
    9. adipogenesis and WNT signalling
    10. adipogenesis and obesity: rounding out the big picture
    11. Transcriptional control of adipogenesis
    12. Transcriptional control of adipogenesis
    13. Differential activation of adipogenesis by multiple PPAR isoforms.
    14. Adipogenesis: forces that tip the scales
    15. Adipogenesis: cellular and molecular aspects
    16. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
    17. Transcriptional regulation of adipogenesis by KLF4
    18. Mitotic clonal expansion: a synchronous process required for adipogenesis
    19. Regulation of PPAR γ activity during adipogenesis
    20. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism
    21. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ
    22. CREB activation induces adipogenesis in 3T3-L1 cells
    23. Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis
    24. Myostatin knockout in mice increases myogenesis and decreases adipogenesis
    25. Retinaldehyde represses adipogenesis and diet-induced obesity
    26. Transcriptional activation of adipogenesis
    27. Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis
    28. Wnt/β-catenin signaling in adipogenesis and metabolism
    29. The regulation of adipogenesis through GPR120
    30. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway
    31. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure
    32. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis
    33. PPARγ and the control of adipogenesis
    34. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription.
    35. Chemerin—a new adipokine that modulates adipogenesis via its own receptor
    36. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity
    37. Vitamin D and adipogenesis: new molecular insights
    38. adipogenesis and aging: does aging make fat go MAD?
    39. Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis
    40. MicroRNA let-7 Regulates 3T3-L1 Adipogenesis
    41. A nuclear receptor atlas: 3T3-L1 adipogenesis
    42. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis
    43. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3‐L1 adipocytes
    44. Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor γ isoforms
    45. PPARγ knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis
    46. An essential regulator of adipogenesis and modulator of fat cell function: PPARγ
    47. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates
    48. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis
    49. A role of miR‐27 in the regulation of adipogenesis
    50. CCAAT/enhancer-binding protein β is required for mitotic clonal expansion during adipogenesis
    51. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications
    52. Evidence of impaired adipogenesis in insulin resistance
    53. NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis
    54. Inhibition of adipogenesis by ghrelin
    55. Reciprocal regulation of adipogenesis by Myc and C/EBPα
    56. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more…
    57. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity
    58. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis
    59. Wnt signaling inhibits adipogenesis through β-catenin-dependent and-independent mechanisms
    60. The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis.
    61. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43
    62. Krox20 stimulates adipogenesis via C/EBPβ-dependent and-independent mechanisms
    63. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis
    64. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles.
    65. Cdk4 promotes adipogenesis through PPARγ activation
    66. Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor α in adipocyte metabolism
    67. adipogenesis in thyroid eye disease
    68. Overexpression of ΔFosB transcription factor (s) increases bone formation and inhibits adipogenesis
    69. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis
    70. Perinatal exposure to bisphenol a alters early adipogenesis in the rat
    71. adipogenesis and fat-cell function in obesity and diabetes
    72. Stromelysin-1 regulates adipogenesis during mammary gland involution
    73. Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis
    74. Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade
    75. Role of Krüppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis
    76. adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels
    77. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects
    78. Inhibition of adipogenesis by the stress‐induced protein CHOP (Gadd153).
    79. Embryonic stem cell-derived adipogenesis
    80. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis.
    81. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone
    82. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow
    83. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis
    84. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2
    85. Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate
    86. HIV protease inhibitors block adipogenesis and increase lipolysis in vitro
    87. Pref-1, a preadipocyte secreted factor that inhibits adipogenesis
    88. Xanthine oxidoreductase is a regulator of adipogenesis and PPARγ activity
    89. Human mesenchymal stem cells as an in vitro model for human adipogenesis
    90. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity
    91. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ
    92. The IRE1α-XBP1 pathway of the unfolded protein response is required for adipogenesis
    93. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice
    94. Inflammation and impaired adipogenesis in hypertrophic obesity in man
    95. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo
    96. Adipogenesis: a cross-talk between cell proliferation and cell differentiation
    97. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes
    98. Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis
    99. New insights into inhibitors of adipogenesis
    100. Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis
    101. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis
    102. The Krüppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-γ expression and adipogenesis
    103. Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis
    104. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?
    105. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
    106. Inhibition of PPARγ2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia
    107. Cathepsin L activity controls adipogenesis and glucose tolerance
    108. OBESITY AND THE ADIPOCYTE PPARγ and the molecular control of adipogenesis
    109. Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis
    110. Interferon regulatory factors are transcriptional regulators of adipogenesis
    111. Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome
    112. Mesenchymal stem cells and adipogenesis in hemangioma involution
    113. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis
    114. Cyclin D1 inhibits peroxisome proliferator-activated receptor γ-mediated adipogenesis through histone deacetylase recruitment
    115. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein β gene during adipogenesis
    116. Proteome analysis of adipogenesis
    117. Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells
    118. Modulating the transcriptional control of adipogenesis
    119. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes
    120. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells
    121. The spatial repositioning of adipogenesis genes is correlated with their expression status in a porcine mesenchymal stem cell adipogenesis model system
    122. ADAM 12 protease induces adipogenesis in transgenic mice
    123. adipogenesis is inhibited by brief, daily exposure to high-frequency, extremely low-magnitude mechanical signals
    124. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein
    125. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor–1 (Pref-1)
    126. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway
    127. SPARC inhibits adipogenesis by its enhancement of β-catenin signaling
    128. Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins
    129. Fibroblast growth factor 1: a key regulator of human adipogenesis
    130. The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response
    131. Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio)
    132. adipogenesis of bovine perimuscular preadipocytes
    133. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis
    134. Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages
    135. Oxygen‐mediated regulation of skeletal muscle satellite cell proliferation and adipogenesis in culture
    136. Glucocorticoid Signaling Defines a Novel Commitment State during adipogenesis In Vitro
    137. Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies
    138. Regulation of adipogenesis and energy balance by PPARγ and PGC-1
    139. Regulation of peroxisome proliferator–activated receptor-γ activity by mammalian target of rapamycin and amino acids in adipogenesis
    140. Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in a cellular model and in mice
    141. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells
    142. Subcutaneous fat in normal and diseased states: 3. Adipogenesis: from stem cell to fat cell
    143. Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3‐L1 adipocytes
    144. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma.
    145. Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable β-catenin signal
    146. Peroxisome proliferator-activated receptor gamma and the control of adipogenesis.
    147. Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis
    148. De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor
    149. Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice
    150. A dominant-negative peroxisome proliferator-activated receptor γ (PPARγ) mutant is a constitutive repressor and inhibits PPARγ-mediated adipogenesis
    151. Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor γ
    152. Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis
    153. The extracellular signal–regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis
    154. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity
    155. Tumour necrosis factor-α inhibits adipogenesis via a β-catenin/TCF4 (TCF7L2)-dependent pathway
    156. The role of adipose protein derived hydrogels in adipogenesis
    157. A role for C/EBPβ in regulating peroxisome proliferator-activated receptor γ activity during adipogenesis in 3T3-L1 preadipocytes
    158. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytes
    159. Temporal gene expression changes during adipogenesis in human mesenchymal stem cells
    160. Sequential gene promoter interactions of C/EBPβ, C/EBPα, and PPARγ during adipogenesis
    161. Role of PPARγ in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18 (INK4c) and p21 (Waf1/Cip1), during adipogenesis
    162. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor γ modulator that promotes adipogenesis
    163. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis
    164. Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells
    165. Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes
    166. The EGF-like protein dlk1 inhibits notch signaling and potentiates adipogenesis of mesenchymal cells
    167. Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism
    168. Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T (1/2) mesenchymal multipotent cells
    169. Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation
    170. Lipin expression preceding peroxisome proliferator-activated receptor-γ is critical for adipogenesis in vivo and in vitro
    171. A human peroxisome‐proliferator‐activated receptor‐γ is activated by inducers of adipogenesis, including thiazolidinedione drugs
    172. Evidence for enhanced adipogenesis in the orbits of patients with Graves’ ophthalmopathy
    173. Ghrelin and Des-Octanoyl Ghrelin Promote adipogenesis Directly in Vivo by a Mechanism Independent of the Type 1a Growth Hormone Secretagogue Receptor
    174. Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARγ2 and C/EBPα gene expression
    175. Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis
    176. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor γ (PPARγ) and C/EBPα gene expression during the …
    177. Sequential phosphorylation of CCAAT enhancer-binding protein β by MAPK and glycogen synthase kinase 3β is required for adipogenesis
    178. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis
    179. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis
    180. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin‐11
    181. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin
    182. Insulin-induced Adipocyte Differentiation ACTIVATION OF CREB RESCUES adipogenesis FROM THE ARREST CAUSED BY INHIBITION OF PRENYLATION
    183. Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells
    184. Chondrogenesis, osteogenesis and adipogenesis of canine mesenchymal stem cells: a biochemical, morphological and ultrastructural study
    185. Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes
    186. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis
    187. adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor γ (PPARγ) and PPARγcoactivator-1 (PGC1)
    188. COUP-TFII acts downstream of Wnt/β-catenin signal to silence PPARγ gene expression and repress adipogenesis
    189. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade
    190. Salt-inducible kinase in steroidogenesis and adipogenesis
    191. Gene expression profiles of early adipogenesis in human mesenchymal stem cells
    192. Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures
    193. Proteomic analysis of primary cultures of human adipose-derived stem cells: modulation by Adipogenesis
    194. Wnt5b partially inhibits canonical Wnt/β-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes
    195. Alcohol-induced adipogenesis in a cloned bone-marrow stem cell
    196. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-γ 2 on thiazolidinedione-induced adipogenesis
    197. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene
    198. Metalloproteases and adipogenesis: a weighty subject
    199. … : RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis
    200. Targeted disruption of the basic Krüppel-like factor gene (Klf3) reveals a role in adipogenesis
    201. Impaired adipogenesis caused by a mutated thyroid hormone α1 receptor
    202. A glucocorticoid‐induced leucine‐zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells
    203. Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells
    204. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone)
    205. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor γ transcriptional activity and repress 3T3-L1 adipogenesis
    206. Phenotypic analysis of Meltrin α (ADAM12)-deficient mice: involvement of Meltrin α in adipogenesis and myogenesis
    207. Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells
    208. Isorhamnetin represses adipogenesis in 3T3‐L1 cells
    209. Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis
    210. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis
    211. Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells
    212. RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity
    213. Side population cells isolated from porcine dental pulp tissue with self‐renewal and multipotency for dentinogenesis, chondrogenesis, adipogenesis, and …
    214. Histone methylation regulator PTIP is required for PPARγ and C/EBPα expression and adipogenesis
    215. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis
    216. Gsα repression of adipogenesis via Syk
    217. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots
    218. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits
    219. The molecular control of adipogenesis, with special reference to lymphatic pathology
    220. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity
    221. Zymosan-induced inflammation stimulates neo-adipogenesis
    222. Contact with existing adipose tissue is inductive for adipogenesis in matrigel
    223. Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis
    224. Wnt/Lrp/β-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARγ and C/EBPα
    225. Basic fibroblast growth factor enhances PPARγ ligand‐induced adipogenesis of mesenchymal stem cells
    226. Retinol saturase promotes adipogenesis and is downregulated in obesity
    227. Altered expression of C/EBP family members results in decreased adipogenesis with aging
    228. Chromatin and chromatin-modifying proteins in adipogenesis
    229. Induction of chondro-, osteo-and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages
    230. Gaining a solid grip on adipogenesis
    231. adipogenesis of murine embryonic stem cells in a three-dimensional culture system using electrospun polymer scaffolds
    232. High extracellular calcium attenuates adipogenesis in 3T3-L1 preadipocytes
    233. Adipogenesis: Usefulness of in vitro and in vivo experimental models,
    234. Comparative transcriptomics of human multipotent stem cells during adipogenesis and osteoblastogenesis
    235. De-novo identification of PPARγ/RXR binding sites and direct targets during adipogenesis
    236. Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures.
    237. Time Course of de Novo adipogenesis in Matrigel by Gelatin Microspheres Incorporating Basic Fibroblast Growth Factor
    238. Salt-inducible kinase (SIK) isoforms: their involvement in steroidogenesis and adipogenesis
    239. … loading down-regulates peroxisome proliferator-activated receptor γ in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis
    240. OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis
    241. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia
    242. Identification of bioactive molecules by adipogenesis profiling of organic compounds
    243. Purification and identification of adipogenesis inhibitory peptide from black soybean protein hydrolysate
    244. A biotin analog inhibits acetyl-CoA carboxylase activity and adipogenesis
    245. The balance between concurrent activation of ERs and PPARs determines daidzein‐induced osteogenesis and adipogenesis
    246. Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis
    247. Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis
    248. Gene expression patterns of bovine perimuscular preadipocytes during adipogenesis
    249. Role of insulin in growth hormone-stimulated 3T3 cell adipogenesis
    250. Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice
    251. Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity.
    252. A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
    253. Esculetin induces apoptosis and inhibits adipogenesis in 3T3‐L1 cells
    254. PPARγ ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis
    255. Differential gene expression of fatty acid binding proteins during porcine adipogenesis
    256. adipogenesis induced by human adipose tissue–derived stem cells
    257. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis
    258. Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition
    259. TSH stimulates adipogenesis in mouse embryonic stem cells
    260. Targeted inactivation of MLL3 histone H3–Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis
    261. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte …
    262. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARγ, adipogenesis, and insulin-responsive hexose transport
    263. Oncostatin M inhibits adipogenesis through the RAS/ERK and STAT5 signaling pathways
    264. Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells
    265. Conditional deletion of β-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium
    266. adipogenesis in a myeloid supporting bone marrow stromal cell line
    267. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor γ during bone morphogenetic protein 2-induced adipogenesis
    268. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution
    269. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5
    270. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation
    271. SPARC functions as an inhibitor of adipogenesis
    272. Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/β-catenin signaling network
    273. Octanoate attenuates adipogenesis in 3T3-L1 preadipocytes
    274. Effects of leptin on apoptosis and adipogenesis in 3T3-L1 adipocytes
    275. Genistein suppresses adipogenesis of 3T3‐L1 cells via multiple signal pathways
    276. Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-β during adipogenesis
    277. RIP140 expression is stimulated by estrogen-related receptor α during adipogenesis
    278. STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation
    279. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin
    280. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis
    281. The nuclear orphan receptor COUP-TFII plays an essential role in adipogenesis, glucose homeostasis, and energy metabolism
    282. Differential expression of signal transducers and activators of transcription during human adipogenesis
    283. The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis
    284. Three-Dimensional in Vitro Model of Adipogenesis: Comparison of Culture Conditions
    285. Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice
    286. Red yeast rice extracts suppress adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 cells
    287. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-γ activation
    288. adipogenesis and IGF-1
    289. New aspects of adipogenesis: radicals and oxidative stress
    290. Decreased fat mass in interleukin-1 receptor antagonist–deficient mice: impact on adipogenesis, food intake, and energy expenditure
    291. Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis
    292. The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells
    293. The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis
    294. HOX gene network is involved in the transcriptional regulation of in vivo human adipogenesis
    295. Bi-directional regulation of brown fat adipogenesis by the insulin receptor
    296. … regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis …
    297. Increased adipogenesis of osteoporotic human‐mesenchymal stem cells (MSCs) characterizes by impaired leptin action
    298. Vitamin K2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures
    299. White Tea extract induces lipolytic activity and inhibits adipogenesis in human subcutaneous (pre)-adipocytes
    300. Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis
    301. Nuclear receptor cofactors in PPARγ-mediated adipogenesis and adipocyte energy metabolism
    302. ETO/MTG8 is an inhibitor of C/EBPβ activity and a regulator of early adipogenesis
    303. Role of follistatin in promoting adipogenesis in women
    304. Hedgehog and adipogenesis: fat and fiction
    305. Cellular and molecular aspects of the regulation of adipogenesis
    306. Diallyl disulfide accelerates adipogenesis in 3T3-L1 cells
    307. Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs
    308. Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells
    309. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front
    310. The effect of pleiotrophin signaling on adipogenesis
    311. Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPARγ pathway
    312. Role of Wnt10b and C/EBPα in spontaneous adipogenesis of 243 cells
    313. A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis
    314. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor α mediated by a tamoxifen-inducible chimeric Cre recombinase …
    315. Activation of CCAAT/enhancer-binding protein (C/EBP) α expression by C/EBPβ during adipogenesis requires a peroxisome proliferator-activated receptor-γ …
    316. … -activated receptor γ/retinoid X receptor α heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive …
    317. Anti‐obesity actions of green tea: Possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis‐related transcription factors
    318. Genistein inhibits CCAAT/enhancer-binding protein β (C/EBPβ) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression
    319. Simultaneous identification of differential gene expression and connectivity in inflammation, adipogenesis and cancer
    320. Control of adipogenesis by fatty acids
    321. Grape-seed derived procyanidins interfere with adipogenesis of 3T3-L1 cells at the onset of differentiation
    322. Novel insights into adipogenesis from omics data
    323. Upregulated expression of stanniocalcin-1 during adipogenesis
    324. Derepression of the C/EBPα gene during adipogenesis: identification of AP-2α as a repressor
    325. CLA differently regulates adipogenesis in stromal vascular cells from porcine subcutaneous adipose and skeletal muscle
    326. Sakuranetin induces adipogenesis of 3T3-L1 cells through enhanced expression of PPARγ2
    327. Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells
    328. Sodium Arsenite Inhibits and Reverses Expression of Adipogenic and Fat Cell-Specific Genes during in Vitro Adipogenesis
    329. ΔFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms
    330. Evodiamine inhibits adipogenesis via the EGFR–PKCα–ERK signaling pathway
    331. Wnt5b stimulates adipogenesis by activating PPARγ, and inhibiting the β-catenin dependent Wnt signaling pathway together with Wnt5a
    332. AMP-activated protein kinase and adipogenesis in sheep fetal skeletal muscle and 3T3-L1 cells
    333. Gene expression profiling of bovine in vitro adipogenesis using a cDNA microarray
    334. Estrogen-related receptor α modulates the expression of adipogenesis-related genes during adipocyte differentiation
    335. adipogenesis licensing and execution are disparately linked to cell proliferation
    336. SLC39A14, a LZT protein, is induced in adipogenesis and transports zinc
    337. Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis
    338. Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro
    339. Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway
    340. Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis
    341. The role of C/EBPδ in the early stages of adipogenesis
    342. Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation
    343. Alkaline phosphatase is involved in the control of adipogenesis in the murine preadipocyte cell line, 3T3-L1
    344. Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging
    345. Changes in mRNA expression of regulatory factors involved in adipocyte differentiation during fatty acid induced adipogenesis in chicken
    346. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development
    347. Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor γ (PPARγ)-interacting protein, is required for PPARγ-mediated adipogenesis
    348. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of …
    349. Adipose thyrotrophin receptor expression is elevated in Graves’ and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo
    350. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin …
    351. The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissue‐derived mesenchymal stem cells
    352. Gap‐junctional communication is required for mitotic clonal expansion during adipogenesis
    353. Membrane proteomic analysis of human mesenchymal stromal cells during adipogenesis
    354. Single-cell profiling reveals the origin of phenotypic variability in adipogenesis
    355. Regulating the balance between peroxisome proliferator-activated receptor γ and β-catenin signaling during adipogenesis A glycogen synthase kinase 3β …
    356. Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on …
    357. Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor γ-stimulated adipogenesis and target gene …
    358. Nonneuronal expression of Rab3A: induction during adipogenesis and association with different intracellular membranes than Rab3D
    359. Clonal preadipocyte cell lines with different phenotypes derived from murine marrow stroma: factors influencing growth and adipogenesis in vitro
    360. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes
    361. A functional peroxisome proliferator-activated receptor-γ ligand-binding domain is not required for adipogenesis
    362. Wnt-signaling is maintained and adipogenesis inhibited by TNFα but not MCP-1 and resistin
    363. Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway
    364. Activated β-catenin induces myogenesis and inhibits adipogenesis in BM-derived mesenchymal stromal cells
    365. Cyclic stretch-induced TGFβ1/Smad signaling inhibits adipogenesis in umbilical cord progenitor cells
    366. Control of adipogenesis in ruminants
    367. Ajoene exerts potent effects in 3T3‐L1 adipocytes by inhibiting adipogenesis and inducing apoptosis
    368. The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity
    369. Bidirectional modulation of adipogenesis by the secreted protein Ccdc80/DRO1/URB
    370. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I
    371. Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor γ expression and adipogenesis in cultured 3T3-L1 cells
    372. Negative regulation of adipogenesis from human mesenchymal stem cells by Jun N-terminal kinase
    373. Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts
    374. Endothelin‐1 inhibits adipogenesis: Role of phosphorylation of Akt and ERK1/2
    375. Peroxisome proliferator-activated receptor γ recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis
    376. adipogenesis inhibitory factor A novel inhibitory regulator of adipose conversion in bone marrow
    377. STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells
    378. Effects of Inorganic HgCl2 on Adipogenesis
    379. … of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose‐derived stromal/stem cell proliferation and adipogenesis
    380. Temporal expression pattern of Bardet-Biedl syndrome genes in adipogenesis
    381. Absence of hormone-sensitive lipase inhibits obesity and adipogenesis in Lepob/ob mice
    382. Rb regulates C/EBPβ-DNA-binding activity during 3T3-L1 adipogenesis
    383. Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes
    384. Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes
    385. P27 knockout mice: reduced myostatin in muscle and altered adipogenesis
    386. Insulin-dependent adipogenesis in stromal ST2 cells derived from murine bone marrow
    387. Ectopic adipogenesis of preconditioned adipose-derived stromal cells in an alginate system
    388. Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells
    389. Progeny from dedifferentiated bovine adipocytes display protracted adipogenesis
    390. Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARγ activation
    391. Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-α-and interleukin-1β-treated …
    392. Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT
    393. FAD24 acts in concert with histone acetyltransferase HBO1 to promote adipogenesis by controlling DNA replication
    394. A dominant negative PPARγ mutant shows altered cofactor recruitment and inhibits adipogenesis in 3T3-L1 cells
    395. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1
    396. Modulation of adipogenesis-related gene expression by estrogen-related receptor γ during adipocytic differentiation
    397. Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis
    398. Inhibition of adipogenesis by RGD-dependent disintegrin
    399. Monocyte chemoattractant protein‐1 and nitric oxide promote adipogenesis in a model that mimics obesity
    400. Regulation of PAI‐1 gene expression during adipogenesis
    401. 1, 25 (OH) 2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated …
    402. Ex vivo expansion, adipogenesis and neurogenesis of cryopreserved human bone marrow mesenchymal stem cells
    403. … expression of interleukin‐11 in bone marrow stromal cells of senescence‐accelerated mice (SAMP6): relationship to osteopenia with enhanced adipogenesis
    404. … protein kinase C to the cell cyele: ectopic expression of PKCll NIH3T3 cells alters the expression of cyelins and Cdk inhibitors and induces adipogenesis
    405. Effect of Zizyphus jujuba Extract on the Inhibition of adipogenesis in 3T3-L1 Preadipocytes
    406. Antiobesity effect of baicalin involves the modulations of proadipogenic and antiadipogenic regulators of the adipogenesis pathway
    407. … adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor γ and sterol regulatory element-binding protein in the regulation of adipogenesis
    408. Transcriptional regulation by the γ5 subunit of a heterotrimeric G protein during adipogenesis
    409. Developmental profile of homeobox gene expression during 3T3-L1 adipogenesis
    410. Akt‐and Foxo1‐interacting WD‐repeat‐FYVE protein promotes adipogenesis
    411. LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue
    412. … anti-diabetic properties of Guazuma ulmifolia Lam are mediated by the stimulation of glucose uptake in normal and diabetic adipocytes without inducing adipogenesis
    413. … decrease fat content and inflammatory cytokines tumor necrosis factor-α and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells
    414. Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors
    415. Sphingosine kinase is induced in mouse 3T3-L1 cells and promotes adipogenesis
    416. Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis
    417. 15-Deoxy-Δ12, 14 prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene
    418. Oxidised LDL modulate adipogenesis in 3T3‐L1 preadipocytes by affecting the balance between cell proliferation and differentiation
    419. adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: biochemical and molecular …
    420. Gsα signalling suppresses PPARγ2 generation and inhibits 3T3L1 adipogenesis
    421. The effects of tumour necrosis factor-α and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis
    422. Roles of fibroblast growth factor 10 (Fgf10) in adipogenesis in vivo
    423. … hormone-related peptide interacts with bone morphogenetic protein 2 to increase osteoblastogenesis and decrease adipogenesis in pluripotent C3H10T½ …
    424. Getting fat: two new players in molecular adipogenesis
    425. The novel gene fad104, containing a fibronectin type III domain, has a significant role in adipogenesis
    426. Prostacyclin as a critical prostanoid in adipogenesis
    427. Adrenomedullin inhibits adipogenesis under transcriptional control of insulin
    428. Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3-L1 adipogenesis
    429. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1
    430. dlk1 specifically interacts with insulin-like growth factor binding protein 1 to modulate adipogenesis of 3T3-L1 cells
    431. Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein β (C/EBPβ) and C/EBPα during adipogenesis
    432. Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARγ2 in 3T3-L1 cells
    433. Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release
    434. MCP-1 (monocyte chemotactic protein-1)-induced protein, a recently identified zinc finger protein, induces adipogenesis in 3T3-L1 pre-adipocytes without peroxisome …
    435. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by antagonists of adipogenesis
    436. The Gs alpha/Gi alpha 2 axis controls adipogenesis independently of adenylylcyclase.
    437. Mesenchymal stem cells from the outer ear: a novel adult stem cell model system for the study of adipogenesis
    438. Developmental effects: oestrogen‐induced vaginal changes and organotin‐induced adipogenesis
    439. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes
    440. Effects of amide constituents from pepper on adipogenesis in 3T3-L1 cells
    441. Ectopic expression of Neuronatin potentiates adipogenesis through enhanced phosphorylation of cAMP-response element-binding protein in 3T3-L1 cells
    442. Rehmannia inhibits adipocyte differentiation and adipogenesis
    443. Proteome analysis of adipocyte lipid rafts reveals that gC1qR plays essential roles in adipogenesis and insulin signal transduction
    444. Tumor necrosis factor-α causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes
    445. Effect of tumor necrosis factor-α, interferon-γ, and transforming growth factor-β on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte …
    446. DEF-1, a novel Src SH3 binding protein that promotes adipogenesis in fibroblastic cell lines
    447. The effect of linseed on intramuscular fat content and adipogenesis related genes in skeletal muscle of pigs
    448. Coregulators in adipogenesis: what could we learn from the SRC (p160) coactivator family?
    449. HIV-1 Nef protein in the nucleus influences adipogenesis as well as viral transcription through the peroxisome proliferator-activated receptors
    450. Gene expression analysis suggests that EBF-1 and PPARγ2 induce adipogenesis of NIH-3T3 cells with similar efficiency and kinetics
    451. Increased TNFα and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis
    452. The novel gene EGFL9/Dlk2, highly homologous to Dlk1, functions as a modulator of adipogenesis
    453. Differentiation‐dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins
    454. Hormonal control of adipogenesis.
    455. Type XVIII collagen is newly transcribed during bovine adipogenesis
    456. Insulin-like growth factor I mediates high-fat diet-induced adipogenesis in Osborne-Mendel rats
    457. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    458. Sequential repression and activation of the CCAAT enhancer-binding protein-α (C/EBPα) gene during adipogenesis
    459. CCAAT/enhancer-binding protein α is required for transcription of the β3-adrenergic receptor gene during adipogenesis
    460. Endocrine regulation of adipogenesis
    461. Effects of the G-protein β3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes
    462. Modulated expression of the epidermal growth factor-like homeotic protein dlk influences stromal-cell–pre-B-cell interactions, stromal cell adipogenesis, and pre-B-cell …
    463. Relationship between the ability to support differentiation of osteoclast-like cells and adipogenesis in murine stromal cells derived from bone marrow
    464. Role of epidermal growth factor and ErbB2 receptors in 3T3‐L1 adipogenesis
    465. Inhibitory effects of A-769662, a novel activator of AMP-activated protein kinase, on 3T3-L1 adipogenesis
    466. … ) promoter: evidence of two cis-regulatory regions, LP-alpha and LP-beta, of importance for the differentiation-linked induction of the LPL gene during adipogenesis.
    467. Emerging concept of adipogenesis regulation by the renin–angiotensin system
    468. Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes
    469. Involvement of PTP-RQ in differentiation during adipogenesis of human mesenchymal stem cells
    470. Enhanced Effects of 1,25(OH)2D3 Plus Genistein on adipogenesis and Apoptosis in 3T3‐L1 Adipocytes
    471. The influence of thiazolidinediones on adipogenesis in vitro and in vivo: Potential modifiers of intramuscular adipose tissue deposition in meat animals,
    472. Albumin inhibits adipogenesis and stimulates cytokine release from human adipocytes
    473. Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesis
    474. Analysis of gene expression during adipogenesis in 3T3‐F442A preadipocytes: Insulin and dexamethasone control
    475. Inhibition of Irvingia gabonensis seed extract (OB131) on adipogenesis as mediated via down regulation of the PPARgamma and leptin genes and up …
    476. Positive regulation of DNA double strand break repair activity during differentiation of long life span cells: the example of adipogenesis
    477. Role of caveolin‐1 and cytoskeletal proteins, actin and vimentin, in adipogenesis of bovine intramuscular preadipocyte cells
    478. Activation of protein kinase B and induction of adipogenesis by insulin in 3T3-L1 preadipocytes: contribution of phosphoinositide-3, 4, 5-trisphosphate versus …
    479. Up-regulation of adipogenin, an adipocyte plasma transmembrane protein, during adipogenesis
    480. Differentiation-dependent expression of Adhfe1 in adipogenesis
    481. Transforming growth factor type β (TGF-β) and adipogenesis in pigs
    482. Role of PPAR γ, transcriptional cofactors, and adiponectin in the regulation of nutrient metabolism, adipogenesis and insulin action: view from the chair
    483. Ubiquitin carboxyl-terminal hydrolase l3 promotes insulin signaling and adipogenesis
    484. The TBN protein, which is essential for early embryonic mouse development, is an inducible TAFII implicated in adipogenesis
    485. … expression profiling of orbital adipose tissue from patients with Graves’ ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis
    486. Regulation of cyclin D1 and Wnt10b gene expression by cAMP-responsive element-binding protein during early adipogenesis involves differential promoter …
    487. Degenerative muscle fiber accelerates adipogenesis of intramuscular cells via RhoA signaling pathway
    488. Temporal activation of Ca2+-calmodulin-sensitive protein kinase type II is obligate for adipogenesis
    489. Differential modulation of 3T3-L1 adipogenesis mediated by 11β-hydroxysteroid dehydrogenase-1 levels
    490. Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MAPK pathways
    491. The NR4A family of orphan nuclear receptors are not required for adipogenesis
    492. Micronutrients affecting adipogenesis in beef cattle
    493. Photocured, styrenated gelatin-based microspheres for de novo adipogenesis through corelease of basic fibroblast growth factor, insulin, and insulin-like growth factor …
    494. Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells
    495. Osteogenesis coordinated in C3H10T1/2 cells by adipogenesis-dependent BMP-2 expression system
    496. Co‐treatment with dexamethasone and octanoate induces adipogenesis in 3T3‐L1 cells
    497. Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4
    498. PPARγ1 synthesis and adipogenesis in C3H10T1/2 cells depends on S‐phase progression, but does not require mitotic clonal expansion
    499. COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves’ ophthalmopathy
    500. Regional variation in adipogenesis and IGF regulatory proteins in the fetal baboon
    501. Reconstituted basement membrane potentiates in vivo adipogenesis of 3T3-F442A cells
    502. Decreased activity and enhanced nuclear export of CCAAT-enhancer-binding protein β during inhibition of adipogenesis by ceramide
    503. Hzf regulates adipogenesis through translational control of C/EBPα
    504. A novel inhibitory protein in adipose tissue, the aldo-keto reductase AKR1B7: its role in adipogenesis
    505. Suppression of 11β-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis
    506. Both wortmannin and simvastatin inhibit the adipogenesis in 3T3-L1 cells during the late phase of differentiation
    507. (−)-Ternatin inhibits adipogenesis and lipid metabolism in 3T3-L1 cells
    508. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation
    509. Inhibition of human mesenchymal stem cell-derived adipogenesis by the environmental contaminant benzo (a) pyrene
    510. Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor
    511. Constitutive coactivator of peroxisome proliferator-activated receptor (PPARγ), a novel coactivator of PPARγ that promotes adipogenesis
    512. Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice
    513. Coadministration of coenzyme Q prevents rosiglitazone-induced adipogenesis in ob/ob mice
    514. Suppression of adipogenesis program in cultured preadipocytes transfected stably with cyclooxygenase isoforms
    515. TCDD administration after the pro-adipogenic differentiation stimulus inhibits PPARγ through a MEK-dependent process but less effectively suppresses adipogenesis
    516. Regulation of Alström syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity
    517. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions
    518. Regulation of porcine adipogenesis in vitro, as compared with other species
    519. Regulation of signal transducers and activators of transcription (STATs) by effectors of adipogenesis: Coordinate regulation of STATs 1, 5A, and 5B with …
    520. Downregulation of protein tyrosine phosphatase PTP-BL represses adipogenesis
    521. Expression regulation and function of Pref-1 during adipogenesis of human mesenchymal stem cells (MSCs)
    522. Differential expression of the peripheral benzodiazepine receptor and gremlin during adipogenesis
    523. Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: adipogenesis/or oedema?
    524. The Werner syndrome protein affects the expression of genes involved in adipogenesis and inflammation in addition to cell cycle and DNA damage responses
    525. Endocrine disrupting organotin compounds are potent inducers of imposex in gastropods and adipogenesis in vertebrates
    526. Cloning and expression of type XII collagen isoforms during bovine adipogenesis
    527. 18α-Glycyrrhetinic acid induces phenotypic changes of skeletal muscle cells to enter adipogenesis
    528. Down-regulation of PPARγ2-induced adipogenesis by PEGylated conjugated linoleic acid as the pro-drug: Attenuation of lipid accumulation and reduction of …
    529. Genomic sequences capable of committing mouse and rat fibroblasts to adipogenesis
    530. Cloning, expression, and differentiation-dependent regulation of SMAF1 in adipogenesis
    531. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-γ pathway
    532. A comparison of thiazolidinedione-induced adipogenesis and myogenesis in stromal-vascular cells from subcutaneous adipose tissue or semitendinosus muscle of …
    533. Ascorbic acid enhances adipogenesis of bone marrow-derived mesenchymal stromal cells
    534. Analysis of the pattern of gene expression during human adipogenesis by DNA microarray
    535. Depot specific differences during adipogenesis of porcine stromal‐vascular cells
    536. FAD24, a regulator of adipogenesis, is required for the regulation of DNA replication in cell proliferation
    537. Identification of amino acid residues of Gsα critical to repression of adipogenesis
    538. An early event in adipogenesis, the nuclear selection of the CCAAT enhancer-binding protein β (C/EBPβ) mRNA by HuR and its translocation to the cytosol
    539. Neudesin, an extracellular heme-binding protein, suppresses adipogenesis in 3T3-L1 cells via the MAPK cascade
    540. Assessing a non-traditional view of adipogenesis: adipocyte dedifferentiation–mountains or molehills?
    541. Effect of plasminogen activator inhibitor-1 on adipogenesis in vivo
    542. … NF-κB-binding sites conserved among mammalian WNT10B orthologs elucidate the TNFα-WNT10B signaling loop implicated in carcinogenesis and adipogenesis
    543. The role of the neuropeptide Y-2 receptor in liporemodeling: NPY mediated adipogenesis and adipose graft maintenance
    544. Regulation of adipogenesis by medium-chain fatty acids in the absence of hormonal cocktail
    545. Skeletal and cardiac myogenesis accompany adipogenesis in P19 embryonal stem cells
    546. In vitro regulation of adipogenesis: tunable engineered tissues
    547. Cell adhesion and spreading affect adipogenesis from embryonic stem cells: the role of calreticulin
    548. Differential effects of heparin and low molecular weight heparin on osteoblastogenesis and adipogenesis in vitro
    549. Transcription factor YY1 promotes adipogenesis via inhibiting CHOP-10 expression
    550. Enhancement of adipogenesis induction by conditioned media obtained from cancer cells
    551. The tyrosine kinase receptor HER2 (erbB‐2): From oncogenesis to adipogenesis
    552. The role of lipin 1 in adipogenesis and lipid metabolism
    553. Site-Related Specificities of the Control by Androgenic Status of adipogenesis and Mitogen-Activated Protein Kinase Cascade/c-fos Signaling Pathways in Rat …
    554. … of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix …
    555. Chemical genetic identification of the histamine H1 receptor as a stimulator of insulin-induced adipogenesis
    556. Probing key targets in insulin signaling and adipogenesis using a methanolic extract of Costus pictus and its bioactive molecule, methyl tetracosanoate
    557. Dominant negative FTase (DNFTα) inhibits ERK5, MEF2C and CREB activation in adipogenesis
    558. The Branch Point Enzyme of the Mevalonate Pathway for Protein Prenylation Is Overexpressed in theob/ob Mouse and Induced by Adipogenesis
    559. Contrary effects of BMP-2 and ATRA on adipogenesis in mouse mesenchymal fibroblasts
    560. Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by interleukin-11/adipogenesis inhibitory factor.
    561. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development
    562. Microarray analysis of early adipogenesis in C3H10T1/2 cells: cooperative inhibitory effects of growth factors and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin
    563. Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats
    564. Expression of growth hormone-independent adipogenesis by a 3T3 cell variant
    565. Down-regulation of aortic carboxypeptidase-like protein during the early phase of 3T3-L1 adipogenesis
    566. Regulation of annexin I in adipogenesis: cAMP-independent action of methylisobutylxanthine
    567. No functional role of plasminogen activator inhibitor‐1 in murine adipogenesis or adipocyte differentiation
    568. Controlling osteogenesis and adipogenesis of mesenchymal stromal cells by regulating a circadian clock protein with laser irradiation
    569. H-89 potentiates adipogenesis in 3T3-L1 cells by activating insulin signaling independently of protein kinase A
    570. Calcineurin‐independent inhibition of 3T3‐L1 adipogenesis by Pasteurella multocida toxin: suppression of Notch1, stabilization of β‐catenin and pre‐adipocyte factor …
    571. Differential role of PPARγ in the regulation of UCP-1 and adipogenesis by TNF-α in brown adipocytes
    572. In vivo gene transfer of PPARγ is insufficient to induce adipogenesis in skeletal muscle
    573. Altered expression of master regulatory genes of adipogenesis in lipomas from patients bearing tRNALys point mutations in mitochondrial DNA
    574. Withaferin A induces apoptosis and inhibits adipogenesis in 3T3‐L1 adipocytes
    575. Inhibition of adipogenesis: a new job for the ER Ca2+ pool
    576. Methods that resolve different contributions of clonal expansion to adipogenesis in 3T3-L1 and C3H10T1/2 cells
    577. Up-regulation of the claudin-6 gene in adipogenesis
    578. Coordinated expression of valine catabolic enzymes during adipogenesis: analysis of activity, mRNA, protein levels, and metabolic consequences
    579. Role of peroxisome proliferator-activated receptor β/δ in chicken adipogenesis
    580. Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone
    581. Transcriptome analysis and promoter sequence studies on early adipogenesis in 3T3-L1 cells
    582. Dual suppression of adipogenesis by cigarette smoke through activation of the aryl hydrocarbon receptor and induction of endoplasmic reticulum stress
    583. Adhesion, proliferation, and adipogenesis in primary rat cell cultures: effects of collagenous substrata, fibronectin, and serum
    584. The nuclear receptor corepressors NCoR and SMRT decrease PPARgamma transcriptional activity and repress 3T3-L1 adipogenesis
    585. Insulin increases the density of potassium channels in white adipocytes: possible role in adipogenesis
    586. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Δ12, 14-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2
    587. Modulator recognition factor-2 is required for adipogenesis in mouse embryo fibroblasts and 3T3-L1 cells
    588. Oxidative stress as a regulator of adipogenesis
    589. Nuclear hormone receptors and adipogenesis
    590. Influence of growth hormone on bone marrow adipogenesis in hypophysectomized rats
    591. Chromosomal localization of nine porcine genes encoding transcription factors involved in adipogenesis
    592. Transcriptional coactivator EDF-1 is required for PPARγ-stimulated adipogenesis
    593. … α and peroxisome proliferator activated receptor-γ proteins in porcine stromal-vascular (SV) cell cultures obtained before and after the onset of fetal adipogenesis
    594. Factors in adipogenesis
    595. Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3‐L1 fibroblast cell line
    596. Altering PPARγ ligand selectivity impairs adipogenesis by thiazolidinediones but not hormonal inducers
    597. Potential role of increased matrix metalloproteinase-2 (MMP2) transcription in impaired adipogenesis in type 2 diabetes mellitus
    598. Relationship between bone metabolism and adipogenesis
    599. Changes in lipid metabolism associated gene transcripts during porcine adipogenesis
    600. Repression of adipogenesis by Adenylyl Cyclase Stimulatory G-protein α Subunit Is Expressed within Region 146-220
    601. Induction of Adenosine 3′,5′-Monophosphate-Dependent Protein Kinase Subunits during adipogenesis in Vitro
    602. … the normoxic activation of the hypoxia‐inducible factor‐1 transcription factor in differentiating 3T3‐L1 preadipocytes: Potential role in the regulation of adipogenesis
    603. Heat stimulation reduces early adipogenesis in 3T3-L1 preadipocytes
    604. … of a novel melanocortin 2 receptor splice variant in murine adipocytes: implications for post-transcriptional control of expression during adipogenesis
    605. FAD24, a regulator of adipogenesis and DNA replication, inhibits H-RAS-mediated transformation by repressing NF-κB activity
    606. … -like growth factor (IGF)-I and-II and IGF binding proteins (IGFBPs) in fetal stromal-vascular (SV) cell cultures obtained before and after the onset of adipogenesis in …
    607. New Insights into MMP function in Adipogenesis
    608. Role and Regulation of PPARγ During Adipogenesis
    609. On the role of placental growth factor in murine adipogenesis
    610. Gene expression profiling reveals a diverse array of pathways inhibited by nuclear receptor SHP during adipogenesis
    611. Oxygen-dependent regulation of adipogenesis
    612. A chromosomal inversion within a quantitative trait locus has a major effect on adipogenesis and osteoblastogenesis
    613. Uncoupling of 3T3‐L1 gene expression from lipid accumulation during adipogenesis
    614. Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity
    615. Ectopic expression of porcine peroxisome proliferator-activated receptor δ regulates adipogenesis in mouse myoblasts
    616. Alcohol-induced regulation of genes involved in bone marrow cell osteogenesis and adipogenesis
    617. The expression of cyclin D1 during adipogenesis in pig primary stromal–vascular cultures
    618. … the SANT domain of tension-induced/inhibited proteins (TIPs), novel partners of the histone acetyltransferase p300, on p300 activity and TIP-6-induced adipogenesis
    619. ApoC‐III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists
    620. Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases …
    621. Inhibition of protein farnesylation arrests adipogenesis and affects PPARγ expression and activation in differentiating mesenchymal stem cells
    622. adipogenesis in nonadherent and adherent bone marrow stem cells grown in fibrin gel and in the presence of adult plasma
    623. Role of modulator recognition factor 2 in adipogenesis and leptin expression in 3T3-L1 cells
    624. Bax inhibitor-1 overexpression reduces the suppressive effect of calcium mobilizing agent on adipogenesis
    625. n-6 Fatty acids and adipogenesis
    626. Identification of differentially expressed genes in a porcine in vivo model of adipogenesis using suppression subtractive hybridization
    627. An Experimental Study of Steroid-induced adipogenesis in Marrow Stromal Cells [J]
    628. … cooperatively suppress peroxisome proliferator-activated receptor-γ1 stimulation and restore focal adhesion complexes during adipogenesis: selective contributions of …
    629. Keystone meeting summary:’Adipogenesis, obesity, and inflammation’and ‘Diabetes mellitus and the control of cellular energy metabolism,’January 21–26, 2006 …
    630. HMGN1 is dispensable for myogenesis and adipogenesis
    631. Involvement of an alternatively spliced mitochondrial oxodicarboxylate carrier in adipogenesis in 3T3-L1 cells
    632. Finkel-Biskis-Reilly Osteosarcoma Virus v-Fos Inhibits adipogenesis and Both the Activity and Expression of CCAAT/Enhancer Binding Protein α, a Key Regulator of …
    633. Inhibition of 3T3 adipogenesis by retinoic acid is not mediated by cytoplasmic retinoic acid-binding protein
    634. Combined effect of C-reactive protein and stavudine on adipogenesis
    635. Endocannabinoid system and pathophysiology of adipogenesis: current management of obesity
    636. Dual effects of sodium tungstate on adipocyte biology: inhibition of adipogenesis and stimulation of cellular oxygen consumption
    637. PPARγ fundamental role in adipogenesis
    638. Expression profile of the genes involved in adipogenesis during porcine preadipocyte differentiation
    639. De novo adipogenesis for reconstructive surgery
    640. Expression of p107 and p130 during human adipose-derived stem cell adipogenesis
    641. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta (12, 14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin …
    642. Effects of fenofibrate on adipogenesis in female C57BL/6J mice
    643. Cryptic fragment α4 LG4‐5 derived from laminin α4 chain inhibits de novo adipogenesis by modulating the effect of fibroblast growth factor‐2
    644. Vitamin C promotes proliferation and differentiation of porcine preadipocytes by modulating transcription of adipogenesis-related genes
    645. Thy-1 expression during 3T3-L1 adipogenesis
    646. Effects of emodin on adipogenesis of marrow stromal cells in vitro
    647. Obesity: adipogenesis and Insulin Resistance.
    648. Cloning, expression, and regulation of bovine cellular retinoic acid-binding protein-II (CRABP-II) during adipogenesis
    649. PPARγ Agonists Down-Regulate the Expression of Atp10c mRNA during Adipogenesis
    650. The endocrine disruptor mono-ethyl-hexyl-phthalate is a selective PPARγ modulator which promotes adipogenesis
    651. Monitoring adipogenesis in tissue-engineered fat in vitro using microscopic magnetic resonance elastography
    652. Transient Expression of c-erbAβ1 Messenger Ribonucleic Acid andβ 1 Thyroid Hormone Receptor Early in adipogenesis of Ob 17 Cells
    653. PPARγ/RXRα Heterodimer Targets Gene of Histone Modification Enzyme PR-Set7/Setd8 and Regulates adipogenesis through a Positive Feedback Loop
    654. The down-regulation of HDACs during adipogenesis differentiation
    655. Activation of C/EBPalpha expression by C/EBPbeta during adipogenesis requires a PPARgamma-associated repression of HDAC1 at the C/EBPalpha gene …
    656. Inhibitory effect of ethyl acetate extract of white peach pericarp on adipogenesis of 3T3-L1 preadipocyte cells
    657. Induction of adipogenesis by the intrasplenic transplantation of chick serum clots
    658. Steroid-induced regulation of gene involved in the osteogenesis and adipogenesis of human bone marrow mesenchymal stem cells
    659. Citri Reticulatae Pericarpium extract suppresses adipogenesis in 3T3‐L1 preadipocytes
    660. Impact of stimulatory pathways on adipogenesis and HIV-therapy associated lipoatrophy
    661. Peroxisome Proliferator–Activated Receptor g and the Transcriptional Control of adipogenesis and Metabolism
    662. Role of protease inhibitors and acylation stimulating protein in the adipogenesis in 3T3-L1 cells
    663. adipogenesis IN STROMAL-VASCULAR CELL CULTURES DERIVED FROM FETAL SEMITENDINOSUS MUSCLE AND SUBCUTANEOUS ADIPOSE TISSUE
    664. Effect of genistein on adipogenesis of 3T3-L1 preadipocytes and its mechanism.
    665. Effect of aspartate and glutamine on a part of the fatty traits and the levels of adipogenesis genes mRNA expression of broiler.
    666. … CCAAT/Enhancer-Binding Protein Site at− 87 Is Required for the Activation of a Novel Murine Melanocortin 2-Receptor Promoter at Late Stages during Adipogenesis
    667. 9th International Conference on Obesity, NIDDM, adipogenesis and insulin resistance
    668. Peroxisome proliferator-activated receptor γ is not associated with adipogenesis in female mice
    669. Inhibition of growth hormone secretagogue receptor antagonist,[D‐Lys‐3]‐GHRP‐6, in adipogenesis of ovine and rat adipocytes
    670. Effects of DHA on Expression of adipogenesis Genes in Mice [J]
    671. Homeobox C8 suppresses adipogenesis of human adipose tissue-derived stem cells
    672. A study on the gene expression in Shikonin-induced inhibition of adipogenesis
    673. The Circadian Clock and Nr2f2 (COUP-TF) regulation of adipogenesis
    674. Antagonism of yuanshi shengmai chenggu capsule on steroid-induced adipogenesis in rat marrow stromal cells
    675. Large scale gene expression profiling during adipogenesis of murine bone marrow stromal cells
    676. Regulation of adipogenesis and adipose maintenance by the mammalian TOR complex 1
    677. Cellular aspects of intramuscular adipogenesis: Competition for cells between muscle and marbling
    678. Suppression of adipogenesis by TCDD: potential for involvement of CYP1B1 and MAP kinase.
    679. Differential Roles of Smad1 and p38 Kinase in the regulation of PPARγ during BMP2-induced Adipogenesis
    680. BONE MARROW adipogenesis IN OSTEOPOROSIS
    681. Muscarinic acetylcholine receptors and adipogenesis
    682. Differential Analysis of Gene Expression During in Vitro adipogenesis in Cattle Using an Adipose Tissue Specific Cdna Microarray
    683. PPARγ in adipogenesis and Insulin Resistance
    684. Essential role of p38 mitogen-activated protein kinase in adipogenesis
    685. Curcumin inhibition of angiogenesis and adipogenesis.
    686. Vitamin D regulation of chemerin in human bone marrow adipogenesis
    687. Resveratrol Inhibits adipogenesis and Induces Apoptosis in 3T3-L1 Adipocytes
    688. The effects of epigallocatechin on adipogenesis of 3T3-L1 preadipocytes
    689. Critical Periods of Human Adipogenesis: The Buccal Fat Pad Model
    690. adipogenesis in mouse 3T3L1 cells: the effects of Rtl1 over-expression
    691. Alcohol-induced adipogenesis in a cloned cell line from bone marrow stroma
    692. Thyrotropin receptor (TSHR) activation in preadipocytes stimulates the early but inhibits the terminal stages of adipogenesis
    693. The role of MAP Kinase in adipogenesis from human bone marrow-derived stromal cells
    694. adipogenesis of adipose stromal cells is reduced by endothelial cell co-cultivation: Role for Wnt-signaling
    695. Adipose tissue engineering. Development of a 3-D model system of adipogenesis
    696. Glucocorticoids are capable of stimulating both lipolysis and adipogenesis in 3T3-L1 adipocytes
    697. Sequential regulation of DGAT2 expression by C/EBPβ and C/EBPα during adipogenesis
    698. In vivo adipogenesis by transplantation of adipose derived stromal cells on injectable scaffold
    699. p21, p27 and p53 Expression during 3T3-L1 adipogenesis and TNF-alpha Induced Apoptosis
    700. Human Adipose Tissue-Derived Stem Cell Seeded Hyaluronic Acid-Collagen Scaffolds for adipogenesis Investigated In Vivo
    701. A Role for Adipocyte-Enriched Transcription Factor, PPAR-γ, in Up-Regulation of PAI-1 Gene Expression during Adipogenesis.
    702. Adipose cell development: The role of fat cell size and tissue-derived growth factors in the process of adipogenesis.
    703. Changes in ECM proteins, decorin and biglycan, during adipogenesis in 3T3-L1 cells and in adipose tissue of mice on a high fat diet
    704. Response to comment on: Harmancey et al.(2007) Adrenomedullin inhibits adipogenesis under transcriptional control of insulin: diabetes 56: 553–563
    705. Effects of 1, 25 dihydroxyvitamin D 3 and dexamethasone on osteogenesis and adipogenesis in human bone marrow cells cultured in human serum
    706. AC/EBP site at 87 is required for the activation of a novel murine melanocortin 2 receptor (MC2-R) promotor at late stages during adipogenesis
    707. Inhibitiory role of curcumin in adipogenesis
    708. Molecular mechanisms of anti-adipogenesis by tumour necrosis factor-alpha
    709. adipogenesis and IGF-1
    710. Control of MC2-R expression during adipogenesis
    711. Not the average view of adipogenesis
    712. adipogenesis and TSH Receptor Expression
    713. Novel mechanisms in PPARy- mediated adipogenesis
    714. adipogenesis in obesity is coupled with angiogenesis
    715. The role of CD1d in adipogenesis
    716. Validation of microRNAs targeting human adipogenesis
    717. adipogenesis on Different Polymeric Materials
    718. Modulators of the adipogenesis of Mesenchymal Stem Cells
    719. The role of GATA transcription factors in adipogenesis.
    720. Analysis of Mitochondria Morphology Dynamics During Adipogenesis
    721. Metabolic Profiling and Flux Analysis of in Vitro Adipogenesis
    722. Understanding adipogenesis: Role of Wnt signaling and glycogen synthase kinase 3.
    723. AW0007 Histamine, a new regulator of adipogenesis?
    724. Pref-1, an inhibitor of adipogenesis.
    725. GATA proteins as molecular gatekeepers of adipogenesis
    726. Ethnic differences in adipogenesis and the role of alkaline phosphatase in the control of adipogenesis in human preadipocytes and 3T3-L1 cells
    727. RAPAMYCIN-SENSITTVE SIGNAL TRANSDUCTION PATHWAYS AND THE CONTROL OF ADIPOGENESIS
    728. adipogenesis using human adipose tissue-derived stem cells
    729. Identification of signalling pathways involved in the transcriptional control of adipogenesis.
    730. Rapamycin-Sensitive Signal Transduction Pathways and the Control of Adipogenesis
    731. Pref 1 and ADSF resistin Soluble Ingibitors of Adipogenesis
    732. Transcriptional regulation of C/EBP alpha expression during adipogenesis
    733. Regulation of PPARgamma activity by mTOR in adipogenesis
    734. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS INDUCE adipogenesis IN MURINE PLURIPOTENT STEM CELLS
    735. Lipidomics of mesenchymal stem cells undergoing adipogenesis
    736. Anthocyaninsinhibit Lipogenesis and adipogenesis of 3T3-L1 preadipocytes
    737. Secretory function of adipose tissue and regulation of adipogenesis [J]
    738. Thiazolidinedione induced adipogenesis in porcine subcutaneous and intramuscular adipose tissue depots
    739. Inhibition of adipogenesis by the c-Myc Oncoprotein
    740. Generation and characterization of mBAP-9, a new in vitro brown adipogenesis model
    741. Regulation of Fat Synthesis and Adipogenesis
    742. Activation of IGF-1 system during adipogenesis
    743. Cannabinoids and regulation of adipogenesis in differentiating 3t3-l1 preadipocytes
    744. ALCOHOL-INDUCED adipogenesis IN BONE AND MARROW: A MECHANISM FOR OSTEONECROSIS
    745. Soy hydrolysates and mate tea polyphenols inhibit in vitro adipogenesis
    746. INCREASED MARROW adipogenesis IN THE MURINE MODEL OF DEFECTIVE OSTEOBLASTOGENESIS 109
    747. Paracrine regulation of angiogenesis and adipogenesis: A potential link with cancer
    748. DEFINED PROTEIN PARTICLES AS SEEDS OF LIPID DROPLETS AND ADIPOGENESIS
    749. Early molecular regulation of adipogenesis in human mesenchymal stem cells
    750. Identification and Functional Characterization of Adipogenesis-related Genes
    751. Retinaldehyde Inhibits adipogenesis Through RXR and PPAR-gamma Repression
    752. Genistein inhibits adipogenesis and increases lipolysis in primary human adipocytes
    753. adipogenesis in post-weanling pigs fed conjugated linoleic acid
    754. Keystone Symposium–Molecular Control of adipogenesis and Obesity
    755. Botanical extracts from St. John’s Wort inhibit adipogenesis and induce insulin resistance
    756. Influence of cytokines on expression of thyrotropin receptor and adipogenesis in patients with Graves ophthalmopathy during the adipogenesis of orbital adipocytes
    757. Ectopic expression of porcine peroxisome-proliferator-activated receptor delta regulates adipogenesis in myoblasts
    758. A proteomics-based approach to investigate proteins associated with adipogenesis
    759. Primary study of steroid-induced adipogenesis in marrow stromal cell
    760. Mis-expressions of SOX9 during Skeletogenesis Lead to Accelerated adipogenesis in Transgenic Mice
    761. Role of PPARδ in the control of adipogenesis by fatty acids.
    762. An investigation of the early molecular regulation of adipogenesis in human mesenchymal stem cells.
    763. Programming Body Composition in Offspring by Maternl Obesity: adipogenesis and wnt/β-catenin signaling
    764. AMP-Activated Protein Kinase Negatively Regulates adipogenesis in Sheep Fetal Skeletal Muscle and 3T3 cells
    765. The effect of metformin-induced AMPK activation on adipogenesis and HIV replication
    766. Single-cell Molecular Profiling of adipogenesis on an Integrated CARS-Confocal Raman Platform
    767. Interaction between Rb and C/EBPβ fails to recruit HDAC during the hypoxic repression of adipogenesis
    768. Regulation of aortic carboxypeptidase-like protein (ACLP) during 3T3-L1 adipogenesis.
    769. … POTENTIAL OF HUMAN PERIPHERAL BLOOD CD34 POSITIVE CELLS FOR OSTEOGENESIS, CHONDROGENESIS AND ADIPOGENESIS.
    770. Adipocyte enhancer binding protein (AEBP1), a multifunctional protein involved in adipogenesis.
    771. Supplemental Data Short Article Interferon-Regulatory Factors Are Transcriptional Regulators of Adipogenesis
    772. Supplemental Data Mediator MED23 Links Insulin Signaling to the adipogenesis Transcription Cascade
    773. Expression and regulation of mitogen-activated protein kinase (MAPK) phosphatases (MKPs) in adipogenesis
    774. #VALUE!
    775. Regulation of circadian rhythms and adipogenesis by the nuclear receptor Rev-erbα
    776. Regulation of adipogenesis by microRNA-378/422b and RNAi associated proteins Dicer and Ago2
    777. The roles of mitotic clonal expansion and the retinoblastoma-related proteins: p107 and p130 during adipogenesis.
    778. C/EBP (alpha), a transcriptional regulator of gadd45, functions in post-mitotic growth control during adipogenesis.
    779. Effect of High-Dose Steroid Treatment on adipogenesis and Secretion of PAI-1 in Rats
    780. Constitutive expression of Jagged-1 in 3T3-L1 preadipocytes suppresses adipogenesis and adipose tissue development
    781. Observation of the morphological change during the adipogenesis differentiation of human bone marrow stromal cell
    782. The effect of Rosiglitazone, an insulin sensitizing drug, on adipogenesis and adipocyte size
    783. Effects of rosiglitazone on expression patterns of the genes involved in adipogenesis during porcine preadipocytes differentiation
    784. Cellular structures involved in albumin interaction with preadipocytes in various stages of adipogenesis, in vitro.
    785. Comparison of the effects of cannabinoid receptor modulation on adipogenesis in human primary preadipocytes and a murine cell line
    786. #VALUE!
    787. A Study on the Mechanisms of the Effect of bFGF on the adipogenesis of MSCs under Clonal Conditions
    788. adipogenesis in Thyroid Eye Disease Exacerbated by Thiazolidenedione Therapy: The Effect of PPAR Agonists and Antagonists on Preadipocyte Differentiation
    789. The role of A-type lamins in adipogenesis and in heat shock response: Implications for human disease.
    790. Targeted disruption of the Basic Krüppel-like Factor (Klf3) gene reveals a role in adipogenesis
    791. Effects of adipogenesis on insulin sensitivity: two time-course studies in diet-induced obese mouse models
    792. The mineralocorticoid receptor induces pro-inflammatory effects in white adipocytes and is essential for adipogenesis
    793. PC54 MATERNAL PARITY: EFFECTS ON adipogenesis AND LEPTIN SYNTHETIC CAPACITY BY ADIPOSE TISSUE DURING POSTNATAL DEVELOPMENT
    794. Rhodiola-induced inhibition of adipogenesis involves dysfunctional antioxidant response associated with proline-linked pentose phosphate pathway
    795. Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4
    796. Alternative mechanisms by which Mediator subunit MED1/TRAP220 regulates PPARγ-stimulated adipogenesis and target gene expression
    797. Multidimensional analysis and functional assignment of DNA-microarray transcription profiles of genes involved in adipogenesis
    798. Matrigel-induced adipogenesis is host rather than graft derived in the murine tissue engineering chamber
    799. An RNA interference-based screen identifies MAP4K4 NIK as a negative regulator of PPAR, adipogenesis, and insulin-responsive hexose transport
    800. Analysis of the Relationship between Globally Regulated Genes and Their Chromosomal Genetic Map Loci during Adipogenesis.
    801. 48 THE SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTORS REPRESSES adipogenesis VIA ITS DISTAL INTERACTING DOMAIN.
    802. Changes in body adipocyte size and density as well as parameters relating to adipogenesis during the growth of the cobia Rachycentron canadum
    803. The anti-adipogenic effect of macrophage-conditioned medium on on 3T3-L1 and human adipogenesis
    804. sLr11, An Enhancer Of Intimal Smooth Muscle Cell Migration, Inhibits Fat Accumulation In Mice As A Novel adipogenesis Regulator
    805. Cryptic fragment? 4 LG4-5 derived from laminin? 4 chain inhibits de novo adipogenesis by modulating the effect of fibroblast growth factor-2
    806. Fine-Tuning of adipogenesis is a Potential Mechanism for Improved Insulin Sensitivity in Human Adipose Tissue with Rosiglitazone Therapy
    807. Mechanisms and countermeasures for reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity
    808. The role of IL-1beta in regulation of adipogenesis, proliferation, and prostaglandin E2 production in normal stromal fibroblasts in breast cancer
    809. Aldehyde oxidase is induced during adipogenesis and is more abundant in visceral when compared to subcutaneous adipose tissue
    810. The role of Mitogen Activated Protein Kinase (MAPK) Phosphatases (MKPs) in adipogenesis: A study of Vaccinia H1-related (VHR) phosphatase
    811. Regulation of Cyclin-dependent Kinase 4 during adipogenesis Involves Switching of Cyclin D Subunits and Concurrent Binding of p18”” and p27′
    812. … of a novel interaction between peroxisome-proliferator activated receptor gamma (PPARγ) and mesoderm induction-early response: implications for adipogenesis
    813. Deletion of Angiotensin II type 2 Receptor Accelerates adipogenesis in Murine Mesenchymal Stem Cells with Wnt 10b/beta-catenin Signaling: Potential Link to …
    814. … Mice Results in Orbital Fat Proliferation and is Elevated in Patient’s Sera with Graves’ Disease and Ophthalmopathy: Further Insight Into Orbital Adipogenesis
    815. An Early Event in Adipogenesis, the Nuclear Selection of the CCAAT Enhancer-binding Protein ß (C/EBP ß) mRNA by HuR and its Translocation to the Cytosol2006
    816. … Induced/inhibited Proteins (TIPs) are novel partners of the histone acetyltransferase p300: TIPs SANT domain in p300 activity and TIP-6-induced adipogenesis
    817. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) and epidermal growth factor (EGF) signaling inhibits in vitro adipogenesis in the mouse embryo fibroblast cell …
    818. Adipocyte and adipogenesis
    819. Long noncoding RNAs regulate adipogenesis
    820. adipogenesis at a glance
    821. Adipogenesis: from stem cell to adipocyte
    822. Adipogenesis
    823. Comparative epigenomic analysis of murine and human adipogenesis
    824. Tracking adipogenesis during white adipose tissue development, expansion and regeneration
    825. The endocannabinoid system links gut microbiota to adipogenesis
    826. Transcriptional networks and chromatin remodeling controlling adipogenesis
    827. microRNAs in the regulation of adipogenesis and obesity
    828. IL-17 regulates adipogenesis, glucose homeostasis, and obesity
    829. Developmental origins of obesity: programmed adipogenesis
    830. miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor γ expression
    831. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis
    832. PPARγ: a circadian transcription factor in adipogenesis and osteogenesis
    833. Regulation of adipogenesis by lymphatic fluid stasis part I: adipogenesis, fibrosis, and inflammation
    834. A deep investigation into the adipogenesis mechanism: Profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/β-catenin signaling …
    835. Histone demethylase LSD1 regulates adipogenesis
    836. IL-17 in obesity and adipogenesis
    837. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle
    838. Extensive chromatin remodelling and establishment of transcription factor ‘hotspots’ during early adipogenesis
    839. Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism
    840. MicroRNA regulation in mammalian adipogenesis
    841. Pref-1, a gatekeeper of adipogenesis
    842. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity
    843. Essential role for miR-196a in brown adipogenesis of white fat progenitor cells
    844. Phytochemicals and adipogenesis
    845. Transcriptional regulation of adipogenesis
    846. Cellular models for understanding adipogenesis, adipose dysfunction, and obesity
    847. Seipin, adipogenesis and lipid droplets
    848. MicroRNAs in adipose tissue: their role in adipogenesis and obesity
    849. Histone H3K9 methyltransferase G9a represses PPARγ expression and adipogenesis
    850. Epigenetic regulation of adipogenesis by histone methylation
    851. New factors controlling the balance between osteoblastogenesis and adipogenesis
    852. MicroRNAs in adipogenesis and as therapeutic targets for obesity
    853. Role of kruppel-like transcription factors in adipogenesis
    854. TLE3 is a dual-function transcriptional coregulator of adipogenesis
    855. Redundant control of adipogenesis by histone deacetylases 1 and 2
    856. Environmental endocrine disruptors promote adipogenesis in the 3t3‐l1 cell line through glucocorticoid receptor activation
    857. In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis
    858. Developmental programming of offspring obesity, adipogenesis, and appetite
    859. Banting Lecture 2012: Regulation of adipogenesis: toward new therapeutics for metabolic disease
    860. C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis
    861. Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways
    862. Staufen1-mediated mRNA decay functions in adipogenesis
    863. Retinoic acid upregulates preadipocyte genes to block adipogenesis and suppress diet-induced obesity
    864. Regulation of adipogenesis by natural and synthetic REV-ERB ligands
    865. Epigenetic regulation of adipogenesis
    866. Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
    867. Temporal profiling of the secretome during adipogenesis in humans
    868. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity
    869. Sex‐and depot‐dependent differences in adipogenesis in normal‐weight humans
    870. MicroRNA‐146b promotes adipogenesis by suppressing the SIRT1‐FOXO1 cascade
    871. Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications
    872. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells
    873. CD36 promotes adipocyte differentiation and adipogenesis
    874. Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARγ activation
    875. Sildenafil promotes adipogenesis through a PKG pathway
    876. Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway
    877. A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-γ nuclear translocation
    878. DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity
    879. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis
    880. TNFα-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors
    881. Autophagy and adipogenesis: implications in obesity and type II diabetes
    882. Stimulation of adipogenesis of adult adipose-derived stem cells using substrates that mimic the stiffness of adipose tissue
    883. C/EBPα regulates SIRT1 expression during adipogenesis
    884. Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow
    885. Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation
    886. Inducible brown adipogenesis of supraclavicular fat in adult humans
    887. Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity
    888. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity
    889. Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4
    890. Anti-cancer role of SPARC, an inhibitor of adipogenesis
    891. Role of histone methylation and demethylation in adipogenesis and obesity
    892. Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis
    893. Obestatin as a regulator of adipocyte metabolism and adipogenesis
    894. Differential redox potential profiles during adipogenesis and osteogenesis
    895. Contrasting effects of A1 and A2b adenosine receptors on adipogenesis
    896. Chemerin, a novel peroxisome proliferator-activated receptor γ (PPARγ) target gene that promotes mesenchymal stem cell adipogenesis
    897. Effects of di (2-ethylhexyl) phthalate (DEHP) on female fertility and adipogenesis in C3H/N mice
    898. Stromal vascular cells and adipogenesis: cells within adipose depots regulate adipogenesis
    899. Epigenetic regulation of adipocyte differentiation and adipogenesis
    900. Regulation of HIF-1α activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia
    901. The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes
    902. Sonic Hedgehog influences the balance of osteogenesis and adipogenesis in mouse adipose-derived stromal cells
    903. Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells
    904. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression
    905. Vitexin, orientin and other flavonoids from Spirodela polyrhiza inhibit adipogenesis in 3T3‐L1 cells
    906. The insulin-like growth factors in adipogenesis and obesity
    907. The Sam68 STAR RNA-binding protein regulates mTOR alternative splicing during adipogenesis
    908. Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells
    909. 17β-Estradiol inhibition of PPARγ-induced adipogenesis and adipocyte-specific gene expression
    910. MCP-1 induced protein promotes adipogenesis via oxidative stress, endoplasmic reticulum stress and autophagy
    911. Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis
    912. Obesity, adipogenesis and insulin resistance
    913. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice
    914. Deletion of the α-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity
    915. ER stress signalling through eIF2α and CHOP, but not IRE1α, attenuates adipogenesis in mice
    916. Krüppel-like factor KLF9 regulates PPAR γ transactivation at the middle stage of adipogenesis
    917. Reorganization of the nuclear lamina and cytoskeleton in adipogenesis
    918. Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner
    919. Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors
    920. Cellular signaling pathways regulating the initial stage of adipogenesis and marbling of skeletal muscle
    921. The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans
    922. Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans
    923. Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor
    924. Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes
    925. Cocoa polyphenols suppress adipogenesis in vitro and obesity in vivo by targeting insulin receptor
    926. Control of adipogenesis by the SUMO-specific protease SENP2
    927. Emerging roles of zinc finger proteins in regulating adipogenesis
    928. Phenolic Compounds from Maté (Ilex paraguariensis) Inhibit adipogenesis in 3T3-L1 Preadipocytes
    929. Development of extracellular matrices mimicking stepwise adipogenesis of mesenchymal stem cells
    930. The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway
    931. MiRNA-181a regulates adipogenesis by targeting tumor necrosis factor-α (TNF-α) in the porcine model
    932. The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis
    933. JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulating C/EBPβ transcription
    934. Antioxidant capacity and in vitro inhibition of adipogenesis and inflammation by phenolic extracts of Vaccinium floribundum and Aristotelia chilensis
    935. Transcription factor Smad3 is required for the inhibition of adipogenesis by retinoic acid
    936. DNA binding-dependent glucocorticoid receptor activity promotes adipogenesis via Krüppel-like factor 15 gene expression
    937. Modulation of intracellular glutathione affects adipogenesis in 3T3‐L1 cells
    938. Regulation of adipogenesis by lymphatic fluid stasis part II: expression of adipose differentiation genes
    939. Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability
    940. Sulforaphane inhibits mitotic clonal expansion during adipogenesis through cell cycle arrest
    941. PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells
    942. Small-molecule activators of AMP-activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis
    943. Exposure to bioaccumulative organochlorine compounds alters adipogenesis, fatty acid uptake, and adipokine production in NIH3T3-L1 cells
    944. Cellular retinol-binding protein type I (CRBP-I) regulates adipogenesis
    945. Cytoskeletal disassembly and cell rounding promotes adipogenesis from ES cells
    946. A functional role for the p62–ERK1 axis in the control of energy homeostasis and adipogenesis
    947. Human but not mouse adipogenesis is critically dependent on LMO3
    948. adipogenesis and insulin sensitivity in obesity are regulated by retinoid‐related orphan receptor gamma
    949. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis
    950. Human Adipose Tissue Extract Induces Angiogenesis and adipogenesis In Vitro
    951. Transactivation of Atg4b by C/EBPβ promotes autophagy to facilitate adipogenesis
    952. Epigenetic regulation of adipogenesis by PHF2 histone demethylase
    953. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early …
    954. The in vitro and in vivo effects of yerba mate (Ilex paraguariensis) extract on adipogenesis
    955. Cross talk between insulin and bone morphogenetic protein signaling systems in brown adipogenesis
    956. Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism
    957. Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis
    958. 6-Gingerol prevents adipogenesis and the accumulation of cytoplasmic lipid droplets in 3T3-L1 cells
    959. A chromatin perspective of adipogenesis
    960. Blueberry peel extracts inhibit adipogenesis in 3T3-L1 cells and reduce high-fat diet-induced obesity
    961. Ankrd26 gene disruption enhances adipogenesis of mouse embryonic fibroblasts
    962. Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans
    963. Adipogenesis: new insights into brown adipose tissue differentiation
    964. A phosphatidic acid binding/nuclear localization motif determines lipin1 function in lipid metabolism and adipogenesis
    965. IL-17 inhibits adipogenesis in part via C/EBPα, PPARγ and Krüppel-like factors
    966. The calcium-sensing receptor promotes adipocyte differentiation and adipogenesis through PPARγ pathway
    967. Large, but not small sustained tensile strains stimulate adipogenesis in culture
    968. Dynamic and distinct histone modifications modulate the expression of key adipogenesis regulatory genes
    969. Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes
    970. Carvacrol prevents diet-induced obesity by modulating gene expressions involved in adipogenesis and inflammation in mice fed with high-fat diet
    971. The changing balance between osteoblastogenesis and adipogenesis in aging and its impact on hematopoiesis
    972. Beta-adrenergic signals regulate adipogenesis of mouse mesenchymal stem cells via cAMP/PKA pathway
    973. Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish
    974. Identification of ZNF395 as a novel modulator of adipogenesis
    975. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of …
    976. Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats
    977. Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase
    978. Induction of dermal collagenesis, angiogenesis, and adipogenesis in human skin by injection of platelet-rich fibrin matrix
    979. Integrative genomics identifies the corepressor SMRT as a gatekeeper of adipogenesis through the transcription factors C/EBPβ and KAISO
    980. An inhibitory effect of resveratrol in the mitotic clonal expansion and insulin signaling pathway in the early phase of adipogenesis
    981. An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis
    982. Imidacloprid, a neonicotinoid insecticide, potentiates adipogenesis in 3T3-L1 adipocytes
    983. Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves’ orbitopathy
    984. GPR103b functions in the peripheral regulation of adipogenesis
    985. Blockade of the activin receptor IIb activates functional brown adipogenesis and thermogenesis by inducing mitochondrial oxidative metabolism
    986. Dexras1 mediates glucocorticoid-associated adipogenesis and diet-induced obesity
    987. Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors
    988. The Effect of Monascus Secondary Polyketide Metabolites, Monascin and Ankaflavin, on adipogenesis and Lipolysis Activity in 3T3-L1
    989. … phosphatase activity modulates phosphatidate levels to promote peroxisome proliferator-activated receptor γ (PPARγ) gene expression during adipogenesis
    990. Cross-talk between interferon-γ and hedgehog signaling regulates adipogenesis
    991. Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity
    992. adipogenesis of human adipose-derived stem cells within three-dimensional hollow fiber-based bioreactors
    993. Adiponectin, adiponectin receptors, and epigenetic regulation of adipogenesis
    994. Enhancement of adipogenesis and fibrogenesis in skeletal muscle of Wagyu compared with Angus cattle
    995. Monoalkylglycerol ether lipids promote adipogenesis
    996. adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms
    997. C1q/tumor necrosis factor-related protein 11 (CTRP11), a novel adipose stroma-derived regulator of adipogenesis
    998. The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signaling
    999. Dermis‐derived hydrogels support adipogenesis in vivo
    1000. Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling
    1001. Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells
    1002. Bone morphogenic proteins signaling in adipogenesis and energy homeostasis
    1003. Mechanical stretch inhibits adipogenesis and stimulates osteogenesis of adipose stem cells
    1004. Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism
    1005. Phosphorylated glucosamine inhibits adipogenesis in 3T3-L1 adipocytes
    1006. The transforming growth factor-beta/bone morphogenetic protein signalling pathway in adipogenesis
    1007. Stimulators of adipogenesis from the marine sponge Xestospongia testudinaria
    1008. Isoprenylated Flavonoids and Adipogenesis-Promoting Constituents from Morus nigra
    1009. Up-regulation of Toll-like receptor 4/nuclear factor-κB signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese …
    1010. Srebf1a is a key regulator of transcriptional control for adipogenesis
    1011. Fine‐tuning BMP7 signalling in adipogenesis by UBE2O/E2‐230K‐mediated monoubiquitination of SMAD6
    1012. Dehydroepiandrosterone (DHEA) treatment in vitro inhibits adipogenesis in human omental but not subcutaneous adipose tissue
    1013. Maternal obesity downregulates microRNA let-7g expression, a possible mechanism for enhanced adipogenesis during ovine fetal skeletal muscle development
    1014. adipogenesis and osteoblastogenesis: trans-differentiation in the pathophysiology of bone disorders
    1015. Dexamethasone modulates osteogenesis and adipogenesis with regulation of osterix expression in rat calvaria‐derived cells
    1016. The promotion of chondrogenesis, osteogenesis, and adipogenesis of human mesenchymal stem cells by multiple growth factors incorporated into nanosphere …
    1017. Effects of Atractylodes macrocephala Koidzumi rhizome on 3T3-L1 adipogenesis and an animal model of obesity
    1018. Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells
    1019. Identification of new genes involved in human adipogenesis and fat storage
    1020. Induction of STEAP4 correlates with 1,25‐dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue
    1021. Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor γ
    1022. Macrophages play a key role in angiogenesis and adipogenesis in a mouse tissue engineering model
    1023. Inhibitory effects of garcinol and pterostilbene on cell proliferation and adipogenesis in 3T3-L1 cells
    1024. Osteoblastogenesis and adipogenesis are higher in osteoarthritic than in osteoporotic bone tissue
    1025. Naringenin inhibits adipogenesis and reduces insulin sensitivity and adiponectin expression in adipocytes
    1026. Regulation of brown fat adipogenesis by protein tyrosine phosphatase 1B
    1027. Serum regulates adipogenesis of mesenchymal stem cells via MEK/ERK‐dependent PPARγ expression and phosphorylation
    1028. Hematopoietic recovery following chemotherapy is improved by BADGE-induced inhibition of adipogenesis
    1029. Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion
    1030. Diallyl trisulfide suppresses the adipogenesis of 3T3-L1 preadipocytes through ERK activation
    1031. Interferon gamma inhibits adipogenesis in vitro and prevents marrow fat infiltration in oophorectomized mice
    1032. Retinoic acid inhibits adipogenesis via activation of Wnt signaling pathway in 3T3-L1 preadipocytes
    1033. Xanthigen suppresses preadipocyte differentiation and adipogenesis through down-regulation of PPARγ and C/EBPs and modulation of SIRT-1, AMPK, and FoxO …
    1034. Involvement of protein tyrosine phosphatases in adipogenesis: New anti-obesity targets?
    1035. Dexamethasone-induced selenoprotein S degradation is required for adipogenesis
    1036. Cyclopia maculata and Cyclopia subternata (honeybush tea) inhibits adipogenesis in 3T3-L1 pre-adipocytes
    1037. Down-regulation of type I Runx2 mediated by dexamethasone is required for 3T3-L1 adipogenesis
    1038. RNA-seq identified a super-long intergenic transcript functioning in adipogenesis
    1039. Polyamine metabolism is involved in adipogenesis of 3T3-L1 cells
    1040. Dieckol, a phlorotannin isolated from a brown seaweed, Ecklonia cava, inhibits adipogenesis through AMP-activated protein kinase (AMPK) activation in 3T3-L1 …
    1041. Isorhamnetin-induced anti-adipogenesis is mediated by stabilization of β-catenin protein
    1042. adipogenesis of adipose-derived stem cells may be regulated via the cytoskeleton at physiological oxygen levels in vitro
    1043. Comparative transcriptome analysis of adipose tissues reveals that ECM-receptor interaction is involved in the depot-specific adipogenesis in cattle
    1044. γ‐secretase inhibitor induces adipogenesis of adipose‐derived stem cells by regulation of Notch and PPAR‐γ
    1045. Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2in vivo
    1046. Negative regulation of adipogenesis by kaempferol, a component of Rhizoma Polygonati falcatum in 3T3-L1 cells
    1047. Group X secretory phospholipase A2 negatively regulates adipogenesis in murine models
    1048. MED14 tethers mediator to the N-terminal domain of peroxisome proliferator-activated receptor γ and is required for full transcriptional activity and adipogenesis
    1049. S100A16 inhibits osteogenesis but stimulates adipogenesis
    1050. Selenate inhibits adipogenesis through induction of transforming growth factor-β1 (TGF-β1) signaling
    1051. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves’ orbitopathy induced by thyrotropin …
    1052. Pomegranate husk extract, punicalagin and ellagic acid inhibit fatty acid synthase and adipogenesis of 3T3-L1 adipocyte
    1053. Association between arsenic suppression of adipogenesis and induction of CHOP10 via the endoplasmic reticulum stress response
    1054. Peripheral fat loss and decline in adipogenesis in older humans
    1055. Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis
    1056. BBS-induced ciliary defect enhances adipogenesis, causing paradoxical higher-insulin sensitivity, glucose usage, and decreased inflammatory response
    1057. Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation
    1058. β-Cryptoxanthin suppresses the adipogenesis of 3T3-L1 cells via RAR activation
    1059. Regulation of Wnt/β‐catenin signaling by CCAAT/enhancer binding protein β during adipogenesis
    1060. Inhi